Skip to main content

Table 2 Amount of cfDNA (ng/ml) and AFP (ng/ml) in plasma samples at the different time points

From: Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

Patients

T1

T2

T3

T4

Median [cfDNA]

cfDNA

cfDNA

cfDNA

cfDNA

AFP

AFP

AFP

AFP

A

na

39.44

8.39

10.11

10.1

85.00

11.00

13.00

6.00

B

12.78

17.68

na

15.30

15.3

373.00

75.00

33.00

45.00

C

4.35

7.34

2.72

3.40

3.9

2.00

3.00

3.00

3.00

D

2.81

14.96

4.18

9.07

6.6

4.00

3.00

9.00

16.00

E

30.63

15.30

17.20

38.62

23.9

3.00

3.00

10.00

42.10

F

28.33

57.12

30.60

14.73

29.5

2.00

4.00

na

4.00

G

10.20

11.90

11.56

20.94

11.7

4.00

6.00

8.00

4.00

H

1.81

5.64

9.38

11.02

7.5

13.00

19.00

30.00

72.00

I

30.37

24.28

7.41

13.33

18.8

1681.00

1685.00

991.00

967.00

J

7.96

na

12.60

160.75

12.6

6154.00

2410.00

8732.00

3855.00

K

2.04

4.42

7.28

9.25

5.8

4.00

3.00

3.00

3.00

L

20.26

16.68

16.68

16.68

16.8

7.00

5.00

6.00

7.00

M

na

na

na

8.98

8.98

9.00

4.00

4.00

6.00

Median [cfDNA]

10.2

15.3

9.3

13.3

 
  1. cfDNA median values are given for each patient at the four time points (last column) or for each time point for all patients (last row)
  2. na, not available